ID   A375-MA2
AC   CVCL_X495
SY   A375-M2; MA-2
DR   ATCC; CRL-3223
DR   cancercelllines; CVCL_X495
DR   Wikidata; Q54606804
RX   PubMed=18505921;
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Derived by intravenous injection of parental cells into nude mice and harvesting of the mung metastases.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-3223
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X494 ! A375-MA1
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 18
//
RX   PubMed=18505921; DOI=10.1158/1541-7786.MCR-07-0344; PMCID=PMC2756991;
RA   Xu L., Shen S.S., Hoshida Y., Subramanian A., Ross K., Brunet J.-P.,
RA   Wagner S.N., Ramaswamy S., Mesirov J.P., Hynes R.O.;
RT   "Gene expression changes in an animal melanoma model correlate with
RT   aggressiveness of human melanoma metastases.";
RL   Mol. Cancer Res. 6:760-769(2008).
//